Manufacturing Capabilities

STELLA has two advanced manufacturing facilities located in Vietnam, one of that is approved by stringent global regulatory authorities such as EMA, PMDA, PIC/S, WHO and other organizations.

Our facilities have integrated international standard in quality systems, documentation system, and processes to ensure its adherence to current Good Manufacturing Practices (cGMP). We focus on large-scale production of formulations in various dosage forms such as tablets, capsules, ointments, creams, etc.

At our facilities, we apply Material Management System (MMS) to ensure material’s assurance and control from the material income to finished product outcome. With a strong and experienced technical team (the One Team); we are confident at our quality that makes us to be the partner of choice for major global pharmaceutical companies.

Annual Production Capacities

  • 2.03billion units of tablets
  • 800million units of capsules
  • 1.50billion units of liquids
  • 1.00million units of ointments

The first facility is located in Hoc Mon district, Ho Chi Minh City approved by local WHO with its commitment to quality at affordable price. At this facility, we maintain the production of various formulations such as oral solid dosage form, ointment, hormone and steroid products, etc.

Here, we produce around 450 million units of oral solid form and more than 1 million units of ointment preparation. We are now development and expand the production to nutraceutical products.

Factory 1

Factory 2

EU-GMP Manufacturing Facility

STELLA’s manufacturing facility in Binh Duong province is located in green field industrial zone (VSIP 1), as our largest manufacturing unit, is capable to produce upto 3 billion units for solid dosage form and 1.2 million liters for liquid dosage form.

This facility has continuously maintained its standards and has been approved from various global health organizations and regulatory authorities including EMA, PMDA, Taiwan FDA, WHO Prequalification, Vietnam WHO, etc.